Chugai Pharmaceutical Co., Ltd. – Strategy, SWOT and Corporate Finance Report

Chugai Pharmaceutical Co., Ltd. – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

Chugai Pharmaceutical (Chugai or 'the company'), the Japanese subsidiary of the Roche Group, is involved in bio pharmaceutical research and development. The company offers medical products and services for the human health. It produces antibody drugs that focus on oncology, renal diseases, immunology and infectious diseases and bone and joint diseases. Chugai's product portfolio includes Actemra (tocilizumab), Alfarol (alfacalcidol), Avastin (bevacizumab), Bonviva (ibandronate sodium hydrate), CellCept (mycophenolate mofetil), Copegus (ribavirin), Edirol (eldecalcitol), Epogin (epoetin beta), Herceptin (trastuzumab), Kytril and Mircera (epoetin beta pegol). The company operates and markets its products in Japan, Switzerland and other regions of the world. It is headquartered in Tokyo, Japan.

Scope

– Detailed information on Chugai Pharmaceutical Co., Ltd. required for business and competitor intelligence needs

– A study of the major internal and external factors affecting Chugai Pharmaceutical Co., Ltd. in the form of a SWOT analysis

– An in-depth view of the business model of Chugai Pharmaceutical Co., Ltd. including a breakdown and examination of key business segments

– Intelligence on Chugai Pharmaceutical Co., Ltd.'s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors

– News about Chugai Pharmaceutical Co., Ltd., such as business expansion, restructuring, and contract wins

– Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of Chugai Pharmaceutical Co., Ltd. and the factors that influence its strategies.

- Track strategic initiatives of the company and latest corporate news and actions.

- Assess Chugai Pharmaceutical Co., Ltd. as a prospective partner, vendor or supplier.

- Support sales activities by understanding your customers' businesses better.

- Stay up to date on Chugai Pharmaceutical Co., Ltd.'s business structure, strategy and prospects.

Table of Contents

Table of Contents

Company Snapshot

Table of Contents

Chugai Pharmaceutical Co., Ltd.: Company Overview

Chugai Pharmaceutical Co., Ltd.: Overview and Key Facts

Chugai Pharmaceutical Co., Ltd.: Overview

Chugai Pharmaceutical Co., Ltd.: Key Facts

Chugai Pharmaceutical Co., Ltd.: Key Employees

Chugai Pharmaceutical Co., Ltd.: Key Employee Biographies

Chugai Pharmaceutical Co., Ltd.: Major Products and Services

Chugai Pharmaceutical Co., Ltd.: Company History

Chugai Pharmaceutical Co., Ltd.: Management Statement

Chugai Pharmaceutical Co., Ltd.: Locations and Subsidiaries

Chugai Pharmaceutical Co., Ltd.: Key Competitors

Chugai Pharmaceutical Co., Ltd.: Company Analysis

Chugai Pharmaceutical Co., Ltd.: Business Description

Chugai Pharmaceutical Co., Ltd.: SWOT Analysis

Chugai Pharmaceutical Co., Ltd.: SWOT Overview

Chugai Pharmaceutical Co., Ltd.: Strengths

Chugai Pharmaceutical Co., Ltd.: Weaknesses

Chugai Pharmaceutical Co., Ltd.: Opportunities

Chugai Pharmaceutical Co., Ltd.: Threats

Chugai Pharmaceutical Co., Ltd.: Corporate Financial Deals Activity

Chugai Pharmaceutical Co., Ltd.: Financial Deals Overview

Chugai Pharmaceutical Co., Ltd.: Targets and Partners

Chugai Pharmaceutical Co., Ltd.: Top Deals 2016 - 2020YTD*

Chugai Pharmaceutical Co., Ltd.: Advisors

Chugai Pharmaceutical Co., Ltd.: Top Legal Advisors

Chugai Pharmaceutical Co., Ltd.: Partnership

Chugai Pharmaceutical Co., Ltd.: Divestments

Chugai Pharmaceutical Co., Ltd.: Recent Developments

Chugai Pharmaceutical Co., Ltd.: News and Events Summary

Chugai Pharmaceutical Co., Ltd.: Business Expansion

Chugai Pharmaceutical Co., Ltd.: Contracts

Chugai Pharmaceutical Co., Ltd.: Corporate Governance

Chugai Pharmaceutical Co., Ltd.: Corporate Social Responsibility

Chugai Pharmaceutical Co., Ltd.: Financial Performance

Chugai Pharmaceutical Co., Ltd.: Market Developments

Chugai Pharmaceutical Co., Ltd.: Regulatory and Legal Events

Chugai Pharmaceutical Co., Ltd.: Research & Development

Chugai Pharmaceutical Co., Ltd.: Strategy and Operations

Appendix

Contact Us

Methodology

About MarketLine

List of Tables

List of Tables

Table 1: Chugai Pharmaceutical Co., Ltd.: Key Facts

Table 2: Chugai Pharmaceutical Co., Ltd.: Key Employees

Table 3: Chugai Pharmaceutical Co., Ltd.: Company History

Table 4: Chugai Pharmaceutical Co., Ltd.: Locations and Subsidiaries

Table 5: Chugai Pharmaceutical Co., Ltd.: Key Competitors

Table 6: Chugai Pharmaceutical Co., Ltd.: Deal Activity by Deal Type – Volume (TTM*)

Table 7: Chugai Pharmaceutical Co., Ltd.: Deal Activity by Deal Type – Volume (2016 – YTD*2020)

Table 8: Chugai Pharmaceutical Co., Ltd.: Targets and Partners

Table 9: Chugai Pharmaceutical Co., Ltd.: Top Deals 2016 – 2020YTD*

Table 10: Chugai Pharmaceutical Co., Ltd.: Legal Advisor Ranking by Value (US$m)

Table 11: Chugai Pharmaceutical Co., Ltd.: Partnership Volume and Value Trend (2016 – YTD*2020)

Table 12: Chugai Pharmaceutical Co., Ltd.: Partnership Trend by Deal Type (2016 – YTD*2020)

Table 13: Chugai Pharmaceutical Co., Ltd.: Divestments Volume and Value Trend (2016 – YTD*2020)

Table 14: Chugai Pharmaceutical Co., Ltd.: Divestments by Geography (2016 – YTD*2020)

Table 15: Chugai Pharmaceutical Co., Ltd.: News and Events Summary

Table 16: Chugai Pharmaceutical Co., Ltd.: Business Expansion

Table 17: Chugai Pharmaceutical Co., Ltd.: Contracts

Table 18: Chugai Pharmaceutical Co., Ltd.: Corporate Governance

Table 19: Chugai Pharmaceutical Co., Ltd.: Corporate Social Responsibility

Table 20: Chugai Pharmaceutical Co., Ltd.: Financial Performance

Table 21: Chugai Pharmaceutical Co., Ltd.: Market Developments

Table 22: Chugai Pharmaceutical Co., Ltd.: Regulatory and Legal Events

Table 23: Chugai Pharmaceutical Co., Ltd.: Research & Development

Table 24: Chugai Pharmaceutical Co., Ltd.: Strategy and Operations

List of Figures

List of Figures

Figure 1: Chugai Pharmaceutical Co., Ltd.: Deal Activity by Deal Type – Volume (TTM*)

Figure 2: Chugai Pharmaceutical Co., Ltd.: Deal Activity by Deal Type – Volume (2016 – YTD*2020)

Figure 3: Chugai Pharmaceutical Co., Ltd.: Partnership Volume and Value Trend (2016 – YTD*2020)

Figure 4: Chugai Pharmaceutical Co., Ltd.: Partnership Trend by Deal Type (2016 – YTD*2020)

Figure 5: Chugai Pharmaceutical Co., Ltd.: Divestments Volume and Value Trend (2016 – YTD*2020)

Figure 6: Chugai Pharmaceutical Co., Ltd.: Divestments by Geography (2016 – YTD*2020)

    Pricing

Discounts available for multiple report purchases.

reportstore@marketline.com
+44 (0) 161 359 5817

Saved reports